These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
691 related items for PubMed ID: 25827976
1. Intellectual abilities in tuberous sclerosis complex: risk factors and correlates from the Tuberous Sclerosis 2000 Study. Bolton PF, Clifford M, Tye C, Maclean C, Humphrey A, le Maréchal K, Higgins JN, Neville BG, Rijsdjik F, Tuberous Sclerosis 2000 Study Group, Yates JR. Psychol Med; 2015 Aug; 45(11):2321-31. PubMed ID: 25827976 [Abstract] [Full Text] [Related]
2. Long-term cognitive outcomes in tuberous sclerosis complex. Tye C, Mcewen FS, Liang H, Underwood L, Woodhouse E, Barker ED, Sheerin F, Yates JRW, Bolton PF, Tuberous Sclerosis 2000 Study Group. Dev Med Child Neurol; 2020 Mar; 62(3):322-329. PubMed ID: 31538337 [Abstract] [Full Text] [Related]
4. Cognitive impairment in tuberous sclerosis complex is a multifactorial condition. Jansen FE, Vincken KL, Algra A, Anbeek P, Braams O, Nellist M, Zonnenberg BA, Jennekens-Schinkel A, van den Ouweland A, Halley D, van Huffelen AC, van Nieuwenhuizen O. Neurology; 2008 Mar 18; 70(12):916-23. PubMed ID: 18032744 [Abstract] [Full Text] [Related]
5. Cyst-like tubers are associated with TSC2 and epilepsy in tuberous sclerosis complex. Chu-Shore CJ, Major P, Montenegro M, Thiele E. Neurology; 2009 Mar 31; 72(13):1165-9. PubMed ID: 19332694 [Abstract] [Full Text] [Related]
6. Epilepsy and Neurodevelopmental Comorbidities in Tuberous Sclerosis Complex: A Natural History Study. Gupta A, de Bruyn G, Tousseyn S, Krishnan B, Lagae L, Agarwal N, TSC Natural History Database Consortium. Pediatr Neurol; 2020 May 31; 106():10-16. PubMed ID: 32139167 [Abstract] [Full Text] [Related]
7. Intellectual development before and after the onset of infantile spasms: a controlled prospective longitudinal study in tuberous sclerosis. Humphrey A, MacLean C, Ploubidis GB, Granader Y, Clifford M, Haslop M, Neville BG, Yates JR, Bolton PF, Tuberous Sclerosis 2000 Study Group. Epilepsia; 2014 Jan 31; 55(1):108-16. PubMed ID: 24417555 [Abstract] [Full Text] [Related]
8. Epilepsy in children with tuberous sclerosis complex: Chance of remission and response to antiepileptic drugs. Overwater IE, Bindels-de Heus K, Rietman AB, Ten Hoopen LW, Vergouwe Y, Moll HA, de Wit MC. Epilepsia; 2015 Aug 31; 56(8):1239-45. PubMed ID: 26046563 [Abstract] [Full Text] [Related]
9. Mental retardation and relation to seizure and tuber burden in tuberous sclerosis complex. Zaroff CM, Barr WB, Carlson C, LaJoie J, Madhavan D, Miles DK, Nass R, Devinsky O. Seizure; 2006 Oct 31; 15(7):558-62. PubMed ID: 16935530 [Abstract] [Full Text] [Related]
10. Epilepsy may be the major risk factor of mental retardation in children with tuberous sclerosis: A retrospective cohort study. Wang YY, Pang LY, Ma SF, Zhang MN, Liu LY, Zou LP. Epilepsy Behav; 2017 Dec 31; 77():13-18. PubMed ID: 29073472 [Abstract] [Full Text] [Related]
11. Infantile spasms and intellectual outcomes in children with tuberous sclerosis complex. Goh S, Kwiatkowski DJ, Dorer DJ, Thiele EA. Neurology; 2005 Jul 26; 65(2):235-8. PubMed ID: 16043792 [Abstract] [Full Text] [Related]
12. Tuberous sclerosis complex: correlation of magnetic resonance imaging (MRI) findings with comorbidities. Wong V, Khong PL. J Child Neurol; 2006 Feb 26; 21(2):99-105. PubMed ID: 16566871 [Abstract] [Full Text] [Related]
13. Tuber Brain Proportion Determines Epilepsy Onset in Children With Tuberous Sclerosis Complex. Zhang F, Xie L, He X, Song X, Zheng H, Wang L, Jiang L. Pediatr Neurol; 2022 Apr 26; 129():39-45. PubMed ID: 35217276 [Abstract] [Full Text] [Related]
14. Electrocorticographic evidence of perituberal cortex epileptogenicity in tuberous sclerosis complex. Ma TS, Elliott RE, Ruppe V, Devinsky O, Kuzniecky R, Weiner HL, Carlson C. J Neurosurg Pediatr; 2012 Nov 26; 10(5):376-82. PubMed ID: 22998031 [Abstract] [Full Text] [Related]
15. Epilepsy in adult patients with tuberous sclerosis complex. Vignoli A, La Briola F, Turner K, Peron A, Vannicola C, Chiesa V, Zambrelli E, Bruschi F, Viganò I, Canevini MP. Acta Neurol Scand; 2021 Jul 26; 144(1):29-40. PubMed ID: 33748956 [Abstract] [Full Text] [Related]
16. Significance of tuber size for complications of tuberous sclerosis complex. Pascual-Castroviejo I, Hernández-Moneo JL, Pascual-Pascual SI, Viaño J, Gutiérrez-Molina M, Velazquez-Fragua R, Quiñones Tapia D, Morales Bastos C. Neurologia; 2013 Jul 26; 28(9):550-7. PubMed ID: 23274119 [Abstract] [Full Text] [Related]
17. Severity of manifestations in tuberous sclerosis complex in relation to genotype. Kothare SV, Singh K, Chalifoux JR, Staley BA, Weiner HL, Menzer K, Devinsky O. Epilepsia; 2014 Jul 26; 55(7):1025-9. PubMed ID: 24917535 [Abstract] [Full Text] [Related]
18. A distinct microRNA expression profile is associated with α[11C]-methyl-L-tryptophan (AMT) PET uptake in epileptogenic cortical tubers resected from patients with tuberous sclerosis complex. Bagla S, Cukovic D, Asano E, Sood S, Luat A, Chugani HT, Chugani DC, Dombkowski AA. Neurobiol Dis; 2018 Jan 26; 109(Pt A):76-87. PubMed ID: 28993242 [Abstract] [Full Text] [Related]